Likewise, TGF-β high gene expression level genotypes were more frequent in all multitreated AIHA patients (75% versus 60%) and CAD subgroup (76% versus 54%) (Supplementary Table 3). Here, TGFB1 is linked to autoimmune hemolytic anemia.